World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
37245
World Ranking
11606
National Ranking
625

Joachim Listing publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Joachim Listing sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 219 publications — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Joachim Listing D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Joachim Listing sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Joachim Listing is affiliated with the Leibniz Institute for Neurobiology in Germany and has dedicated their research primarily to the field of medicine, with a focus on rheumatology. Their work spans related subfields such as hematology, pharmacology, immunology, and clinical psychology.

Their recent publications demonstrate involvement in clinical trials and observational studies addressing autoimmune and inflammatory disorders, as well as treatments targeting rheumatic diseases. Notable papers include:

  • Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial (2020, Annals of the Rheumatic Diseases)
  • Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial (2021, RMD Open)
  • Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial (2024, Annals of the Rheumatic Diseases)
  • Implementing an automated monitoring process in a digital, longitudinal observational cohort study (2021, Arthritis Research & Therapy)
  • Distinct Effects of Interleukin-1β Inhibition upon Cytokine Profile in Patients with Adult-Onset Still's Disease and Active Articular Manifestation Responding to Canakinumab (2021, Journal of Clinical Medicine)

Joachim Listing frequently collaborates with a group of researchers, including:

  • Joachim Sieper
  • Claudia Kedor
  • Fabian Proft
  • Valeria Ríos Rodríguez
  • Mikhail Protopopov

Their publications are commonly found in several medical journals such as:

  • Annals of the Rheumatic Diseases
  • RMD Open
  • Arthritis Research & Therapy
  • Journal of Clinical Medicine
  • The Journal of Rheumatology

The research topics covered by Joachim Listing include:

  • Spondyloarthritis Studies and Treatments
  • Autoimmune and Inflammatory Disorders Research
  • Rheumatoid Arthritis Research and Therapies
  • Otitis Media and Relapsing Polychondritis
  • Pharmacological Effects of Natural Compounds
  • Psoriasis: Treatment and Pathogenesis
  • Inflammatory mediators and NSAID effects

Joachim Listing's work advances knowledge on the pharmacological and clinical aspects of rheumatic diseases, particularly in relation to immunological mechanisms and therapeutic interventions involving biologics and anti-inflammatory agents.

Best Publications

  • The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

    M Rudwaleit;D van der Heijde;R Landewé;J Listing

  • American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang

  • Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

    J Braun;J Brandt;J Listing;A Zink

  • The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

    M Rudwaleit;R Landewé;D van der Heijde;J Listing

  • Infections in patients with rheumatoid arthritis treated with biologic agents.

    Joachim Listing;Anja Strangfeld;Sonja Kary;Rolf Rau

  • The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.

    Martin Rudwaleit;Hildrun Haibel;Xenofon Baraliakos;Joachim Listing

  • ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis

    D van der Heijde;E Lie;T K Kvien;J Sieper

  • Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents

    Anja Strangfeld;Joachim Listing;Peter Herzer;Anke Liebhaber

  • Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria.

    Martin Rudwaleit;Anke Metter;Joachim Listing;Joachim Sieper

  • Six‐month results of a double‐blind, placebo‐controlled trial of etanercept treatment in patients with active ankylosing spondylitis

    J. Brandt;A. Khariouzov;J. Listing;H. Haibel

  • The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment

    Joachim Listing;Kerstin Gerhold;Angela Zink

  • Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis

    Martin Rudwaleit;Joachim Listing;Jan Brandt;Jürgen Braun

  • Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: Evaluation of a new scoring system

    J. Braun;X. Baraliakos;W. Golder;J. Brandt

  • Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis

    Denis Poddubnyy;Hildrun Haibel;Joachim Listing;Elisabeth Märker-Hermann

  • Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanercept

    J. Braun;X. Baraliakos;J. Listing;J. Sieper

  • Long-term outcome in patients with juvenile idiopathic arthritis.

    Kirsten Minden;Martina Niewerth;Joachim Listing;Thomas Biedermann

  • Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers.

    A Zink;J Braun;J Listing;J Wollenhaupt

  • Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

    A Strangfeld;M Eveslage;M Schneider;H J Bergerhausen

  • Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis

    Denis Poddubnyy;Martin Rudwaleit;Hildrun Haibel;Joachim Listing

  • Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two†

    Hildrun Haibel;Martin Rudwaleit;Joachim Listing;Frank Heldmann

Frequent Co-Authors

Joachim Sieper
Joachim Sieper Charité - University Medicine Berlin
Xenofon Baraliakos
Xenofon Baraliakos Ruhr University Bochum
Jürgen Braun
Jürgen Braun Rheumazentrum Ruhrgebiet
Martin Rudwaleit
Martin Rudwaleit Ghent University
Robert Landewé
Robert Landewé University of Amsterdam
Kimme L. Hyrich
Kimme L. Hyrich University of Manchester
Johan Askling
Johan Askling Karolinska Institute
Maxime Dougados
Maxime Dougados Hôpital Cochin
Xavier Mariette
Xavier Mariette University of Paris-Saclay
Paul Emery
Paul Emery University of Leeds

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens doors to numerous allied health fields and online degree options. For those interested in patient care but looking for an alternative entry path, consider exploring a nursing school without teas test requirements, which can streamline your path into nursing.

Another popular and versatile option is to pursue a degree in healthcare administration. This direction is ideal for students interested in hospital management, leadership, or healthcare policy, and many programs are now available fully online for maximum flexibility.

If you are a nurse seeking advanced practice, consider programs designed for career progression, such as specialized adn to np bridge programs. These accelerated pathways help registered nurses quickly move towards nurse practitioner roles.

For those interested in disease prevention and wellness, pursuing online nutrition degrees can lead to careers in dietary counseling, education, and community health. Each of these online programs can complement or offer alternatives to traditional medical studies.

Best Scientists Citing Joachim Listing

Trending Scientists

Recently Published Articles